Pubblicazioni

Soluble CD163 in CMV-Infected and CMV-Uninfected subjects on virologically suppressive antiretroviral therapy in the ICONA Cohort

2017 - JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Vita, S; Lichtner, M; Marchetti, G; Mascia, C; Merlini, E; Cicconi, P; Vullo, V; Viale, P; Costantini, A; DÊ¼Arminio Monforte, A; ICONA Foundation Study, Group

Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-ÃÂ³)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection

2017 - CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY

Mascia, Claudia; Lichtner, Miriam; ZuccalÃ£Â , Paola; Vita, Serena; Tieghi, Tiziana; Marocco, Raffaella; Savinelli, Stefano; Rossi, Raffaella; Iannetta, Marco; Campagna, Michela; Schiavone, Francesco; Mengoni, Fabio; Russo, Gianluca; Mastroianni, Claudio Maria; Vullo, Vincenzo

Pubblicazioni

Soluble CD163 in CMV-Infected and CMV-Uninfected subjects on virologically suppressive antiretroviral therapy in the ICONA Cohort

Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-ÃÂ³)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection

Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-ÃÂ³)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection